Back
Biohaven Vs. Arrowhead Pharmaceuticals Industry Stock Comparison
Sell
31
BHVN
Biohaven
Last Price:
37.33
Seasonality Move:
53.12%
Sell
16
ARWR
Arrowhead Pharmaceuticals
Last Price:
22.89
Seasonality Move:
2.52%
Sell
31
Biohaven (BHVN)
is a Sell
Is Biohaven a Buy, Sell or Hold?
- The current Biohaven [BHVN] share price is $33.78. The Score for BHVN is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- BHVN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
16
Arrowhead Pharmaceuticals (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals a Buy, Sell or Hold?
- The current Arrowhead Pharmaceuticals [ARWR] share price is $22.06. The Score for ARWR is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- ARWR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ARWR Stock Price Chart
What is Arrowhead Pharmaceuticals's stock price today?
-
The Arrowhead Pharmaceuticals share price today is $22.06
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARWR is experiencing slight selling pressure.
BHVN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.94 | Sell |
| Relative Strength Index (14 RSI): | 26.53 | Sell |
| Chaikin Money Flow: | -1614760 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.97 - 47.13) | Sell |
| Bollinger Bands (100): | (40.82 - 53.38) | Sell |
ARWR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.7 | Sell |
| Relative Strength Index (14 RSI): | 37.01 | Sell |
| Chaikin Money Flow: | -507790 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.5 - 25.02) | Sell |
| Bollinger Bands (100): | (25.11 - 33.77) | Sell |
BHVN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.36 | Sell |
| 20-day SMA: | 39.84 | Sell |
| 50-day SMA: | 48.94 | Sell |
| 200-day SMA: | 36.1 | Sell |
| 8-day EMA: | 38.38 | Sell |
| 20-day EMA: | 41.02 | Sell |
| 50-day EMA: | 44.77 | Sell |
| 200-day EMA: | 38.18 | Sell |
ARWR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.11 | Sell |
| 20-day SMA: | 23.4 | Sell |
| 50-day SMA: | 26.37 | Sell |
| 200-day SMA: | 28.4 | Sell |
| 8-day EMA: | 23.52 | Sell |
| 20-day EMA: | 23.99 | Sell |
| 50-day EMA: | 25.82 | Sell |
| 200-day EMA: | 28.98 | Sell |
Biohaven Earnings Growth & BHVN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.63 per share, an increase next quarter of $0.43 per share, a decrease this year of $2.58 per share, and an increase next year of $2.09 per share.
Arrowhead Pharmaceuticals Earnings Growth & ARWR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.02 per share, a decrease this year of $1.62 per share, and an increase next year of $0.15 per share.
Biohaven Technical Analysis
| Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arrowhead Pharmaceuticals Technical Analysis
| Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||